PTGS2 and cancer: In cancer patients, ascorbate at millimolar concentrations has been shown to decrease inflammation through suppression of cyclooxygenase 2 (COX-2) and activation of nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) in endothelial cells [43].